Open Beta
MetriLume

US marketsOSCR

SEC-sourced researchBeta

OSCR

Oscar Health, Inc.

Company comparison ↗

Data passport

CIK
0001568651
Exchange
NYSE
Business activity
— · SIC 6324
Financial inputs
6/6
Filing date
Sep 22, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 21,353,000.0000 USD; December 2024: 20,576,000.0000 USD; December 2025: 28,593,000.0000 USD28.6M USD0 USD0December 2023December 2024December 2025
OSCR · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202321,353,000.0000Feb 13, 2026
December 202420,576,000.0000Feb 13, 2026
December 202528,593,000.0000Feb 13, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202528,593,000.0000-443,151,000.00001,094,854,000.00006,325,411,000.00005,344,676,000.0000Feb 13, 2026
December 202420,576,000.000025,432,000.0000978,193,000.00004,840,496,000.00003,824,071,000.0000Feb 13, 2026
December 202321,353,000.0000-270,728,000.0000-272,159,000.0000——Feb 13, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$28.59MDecember 2025Feb 13, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$20.58MDecember 2024Feb 13, 202610-K
Net incomeNetIncomeLoss-$443.15MDecember 2025Feb 13, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.09BDecember 2025Feb 13, 202610-K
Total assetsAssets$6.33BDecember 2025Feb 13, 202610-K
Total liabilitiesLiabilities$5.34BDecember 2025Feb 13, 202610-K

New filings

Explore methodology ↗